Akin Atmaca

6.2k citations
61 papers · 3.3k · 2 hit papers · h-index 24

Impact in

  • Oncology top 1%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • Gastrointestinal Tumor Research and Treatment

Papers in

    • Cancer Immunotherapy and Biomarkers 13
    • Colorectal Cancer Treatments and Studies 11
    • Lung Cancer Research Studies 11
    • Peptidase Inhibition and Analysis 7
    • Lung Cancer Treatments and Mutations 12
    • Gastric Cancer Management and Outcomes 11

Akin Atmaca

54 papers receiving 3.3k citations

Akin Atmaca's Hit Papers

Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer 2018 · 670 citations
6700+6+12Years since publication200400600

Peers

Akin Atmaca
Comparison fields: 5 of 93
  • Oncology 2.2k
  • Gastroenterology 344
  • Pulmonary and Respiratory Medicine 1.4k
  • Immunology 505
  • Cancer Research 304
Replace Geoffrey Y. Ku with:
Geoffrey Y. Ku United States
Atsuo Takashima Japan
Zhi Peng China
Philippe Tanière United Kingdom
Feng‐Hua Wang China
Yoshitaka Honma Japan
Jerome C. Landry United States
Young Soo Park South Korea
Claudia Pauligk Germany
T Kosuge Japan
Akin Atmaca relative to Geoffrey Y. Ku United States Geoffrey Y. Ku's profile →
Citations per field
00.5×1.5×
Geoffrey Y. Ku · 1×
Citations per year

Countries citing papers authored by Akin Atmaca

Since Specialization
Citations

This map shows the geographic impact of Akin Atmaca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akin Atmaca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akin Atmaca more than expected).

Fields of papers citing papers by Akin Atmaca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akin Atmaca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akin Atmaca. The network helps show where Akin Atmaca may publish in the future.

Co-authors

The 25 scholars most cited alongside Akin Atmaca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Akin Atmaca Line = papers co-authored together Akin Atmaca links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
Hit paper breakdown →
2018670
2
Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
Hit paper breakdown →
2008568
3 2018233
4 2019218
5 2008183
6 2007160
7 2004152
8 200575
9 201175
10 201165
11 201063
12 201761
13 200659
14 201654
15 200553
16
LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.
200747
17 200644
18 201243
19 201341
20 200831

About Akin Atmaca

Akin Atmaca is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Surgery, having authored 61 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), Immunotherapy and Immune Responses (13 papers), Lung Cancer Treatments and Mutations (12 papers), Colorectal Cancer Treatments and Studies (11 papers), Lung Cancer Research Studies (11 papers), Gastric Cancer Management and Outcomes (11 papers), Histone Deacetylase Inhibitors Research (7 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Oncology (2.2k citations), Gastroenterology (344 citations), Pulmonary and Respiratory Medicine (1.4k citations), Immunology (505 citations) and Cancer Research (304 citations). Akin Atmaca has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Elke Jäger, Alexander Knuth, Salah‐Eddin Al‐Batran, Claudia Pauligk, Matthew D. Hellmann, Scott Antonia, Paolo A. Ascierto, Emiliano Calvo, Margaret K. Callahan and G. Seipelt. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, International Journal of Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact